Stephanie Grond
Research Subjects
Research Interests
Stephanie Grond has a total of 300 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Kulik
Eberhard Karls University Tübingen Auf der Morgenstelle 28
10 shared publications - Tilmann Weber
Technical University of Denmark
9 shared publications - Anne Berscheid
German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany
7 shared publications - Heike Brötz-Oesterhelt
Interfaculty Institute of Microbiology and Infection Medicine, Microbial Bioactive Compounds, University of Tübingen Tübingen Germany
7 shared publications - Bernhard Krismer
Department of Infection Biology, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen
6 shared publications Paultheo von Zezschwitz
6 shared publications
Latest Publications
- Open Access
- 25 June 2025
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 88 (7) , 1719-1728
Genome Mining Leads to the Discovery of Kasichelins A–D, Unusual β-Alanine- and β-Aminoisobutyric Acid-Containing Siderophores from Streptomyces
Genome mining of a Streptomyces strain collected in Tanzania revealed its potential to produce a novel siderophore. Heterologous expression of the corresponding biosynthetic gene cluster (BGC) in S. coelicolor M512 resulted in the production of kasichelin A, a new metal-chelating molecule featuring a phenolate oxazoline and a hydroxamate moiety as iron-binding ligands connected via a β-aminoisobutyric acid (BAIBA) linker. Further analysis of the heterologous producer and subsequent optimization of the culture conditions for the wild-type strain led to the isolation of three additional congeners, kasichelins B, C, and D. Marfey's analysis of kasichelin C, the most abundant congener, established its absolute configuration as 2R,7R,10S,11R. Notably, kasichelin C was found to be identical to L-654,040, a partially characterized compound previously described in the patent literature. The iron-binding properties of the kasichelins were evaluated using the chrome azurol S (CAS) assay, UV/vis spectroscopy, and electrospray ionization-mass spectrometry (ESI-MS). All four kasichelins exhibit comparable iron(III)-binding affinities and surpass deferoxamine in their ability to sequester the metal, despite natural variations in their ligands and linker structures. The biosynthetic origin of the unusual BAIBA moiety presents an intriguing direction for future research.
- 25 June 2025
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 88 (7) , 1719-1728
Open AccessGenome Mining Leads to the Discovery of Kasichelins A–D, Unusual β-Alanine- and β-Aminoisobutyric Acid-Containing Siderophores from Streptomyces
Genome mining of a Streptomyces strain collected in Tanzania revealed its potential to produce a novel siderophore. Heterologous expression of the corresponding biosynthetic gene cluster (BGC) in S. coelicolor M512 resulted in the production of kasichelin A, a new metal-chelating molecule featuring a phenolate oxazoline and a hydroxamate moiety as iron-binding ligands connected via a β-aminoisobutyric acid (BAIBA) linker. Further analysis of the heterologous producer and subsequent optimization of the culture conditions for the wild-type strain led to the isolation of three additional congeners, kasichelins B, C, and D. Marfey's analysis of kasichelin C, the most abundant congener, established its absolute configuration as 2R,7R,10S,11R. Notably, kasichelin C was found to be identical to L-654,040, a partially characterized compound previously described in the patent literature. The iron-binding properties of the kasichelins were evaluated using the chrome azurol S (CAS) assay, UV/vis spectroscopy, and electrospray ionization-mass spectrometry (ESI-MS). All four kasichelins exhibit comparable iron(III)-binding affinities and surpass deferoxamine in their ability to sequester the metal, despite natural variations in their ligands and linker structures. The biosynthetic origin of the unusual BAIBA moiety presents an intriguing direction for future research.
- Open Access
- 24 June 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (26) , 14048-14057
Multicolumn Two-Dimensional Liquid Chromatography Screening Platform for Stereopeptidomics and Application to Antimicrobial Peptide Polyene and Lipopeptide
Therapeutic peptides are a rapidly growing field in research and drug development. While the majority of natural and synthetic therapeutic peptides have l-amino acids as building blocks, d-amino acid-containing peptides are found frequently in nonribosomal peptides or can be formed during peptide synthesis by epimerization. Thus, analytical methods are needed for the quality control of stereointegrity and the determination of absolute configurations. Enantioselective amino acid analysis following complete hydrolysis is indispensable in the field but leads to the loss of sequence information, i.e., the position of d-amino acids can no longer be unambiguously assigned. Here, we propose a multicolumn two-dimensional liquid chromatography-tandem high-resolution mass spectrometry (2D LC-HRMS) platform with multiple reversed-phase type columns (C18, charged surface hybrid C18, mixed-mode C18 AX) in the first dimension (1D) and multiple chiral columns in the second dimension (2D) (teicoplanin, teicoplanin aglycone, crown ether, and zwitterionic quinine and quinidine carbamate-based chiral stationary phases). It allows the combination of distinct 1D columns (for peptide epimer/diastereomer separations) and 2D columns (for peptide enantiomer separations), enabling the full resolution of complex peptide stereoisomer mixtures. The utility of this 2D-LC platform for peptide analyses was demonstrated for a tetrapeptide amide from an antimicrobial peptide polyene natural product and a lipopeptide, digested into dipeptides for middle-down/middle-up stereoselective peptide analysis. Multiple heart-cutting and selective comprehensive 2D-LC, respectively, with active solvent modulation and sequential window acquisition of all theoretical fragment ion spectra mass spectrometry (SWATH-MS) enabled the full separation of all stereoisomers and the clarification of the configurations of all sample peptides. Such a 2D-LC-HRMS screening platform can be valuable as an efficient and fast generic approach for streamlining method development in the pharmaceutical industry.
- 24 June 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (26) , 14048-14057
Open AccessMulticolumn Two-Dimensional Liquid Chromatography Screening Platform for Stereopeptidomics and Application to Antimicrobial Peptide Polyene and Lipopeptide
Therapeutic peptides are a rapidly growing field in research and drug development. While the majority of natural and synthetic therapeutic peptides have l-amino acids as building blocks, d-amino acid-containing peptides are found frequently in nonribosomal peptides or can be formed during peptide synthesis by epimerization. Thus, analytical methods are needed for the quality control of stereointegrity and the determination of absolute configurations. Enantioselective amino acid analysis following complete hydrolysis is indispensable in the field but leads to the loss of sequence information, i.e., the position of d-amino acids can no longer be unambiguously assigned. Here, we propose a multicolumn two-dimensional liquid chromatography-tandem high-resolution mass spectrometry (2D LC-HRMS) platform with multiple reversed-phase type columns (C18, charged surface hybrid C18, mixed-mode C18 AX) in the first dimension (1D) and multiple chiral columns in the second dimension (2D) (teicoplanin, teicoplanin aglycone, crown ether, and zwitterionic quinine and quinidine carbamate-based chiral stationary phases). It allows the combination of distinct 1D columns (for peptide epimer/diastereomer separations) and 2D columns (for peptide enantiomer separations), enabling the full resolution of complex peptide stereoisomer mixtures. The utility of this 2D-LC platform for peptide analyses was demonstrated for a tetrapeptide amide from an antimicrobial peptide polyene natural product and a lipopeptide, digested into dipeptides for middle-down/middle-up stereoselective peptide analysis. Multiple heart-cutting and selective comprehensive 2D-LC, respectively, with active solvent modulation and sequential window acquisition of all theoretical fragment ion spectra mass spectrometry (SWATH-MS) enabled the full separation of all stereoisomers and the clarification of the configurations of all sample peptides. Such a 2D-LC-HRMS screening platform can be valuable as an efficient and fast generic approach for streamlining method development in the pharmaceutical industry.
- Open Access
- 8 August 2024
- Published by Springer Nature in Nature Microbiology
- Vol. 9 (12) , 3393
Author Correction: Commensal production of a broad-spectrum and short-lived antimicrobial peptide polyene eliminates nasal Staphylococcus aureus
- 8 August 2024
- Published by Springer Nature in Nature Microbiology
- Vol. 9 (12) , 3393
Open AccessAuthor Correction: Commensal production of a broad-spectrum and short-lived antimicrobial peptide polyene eliminates nasal Staphylococcus aureus
- Open Access
- 25 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
The antimicrobial fibupeptide lugdunin forms water-filled channel structures in lipid membranes
Recently, a novel cyclo-heptapeptide composed of alternating d,l-amino acids and a unique thiazolidine heterocycle, called lugdunin, was discovered, which is produced by the nasal and skin commensal Staphylococcus lugdunensis. Lugdunin displays potent antimicrobial activity against a broad spectrum of Gram-positive bacteria, including challenging-to-treat methicillin-resistant Staphylococcus aureus (MRSA). Lugdunin specifically inhibits target bacteria by dissipating their membrane potential. However, the precise mode of action of this new class of fibupeptides remains largely elusive. Here, we disclose the mechanism by which lugdunin rapidly destabilizes the bacterial membrane potential using an in vitro approach. The peptide strongly partitions into lipid compositions resembling Gram-positive bacterial membranes but less in those harboring the eukaryotic membrane component cholesterol. Upon insertion, lugdunin forms hydrogen-bonded antiparallel β-sheets by the formation of peptide nanotubes, as demonstrated by ATR-FTIR spectroscopy and molecular dynamics simulations. These hydrophilic nanotubes filled with a water wire facilitate not only the translocation of protons but also of monovalent cations as demonstrated by voltage-clamp experiments on black lipid membranes. Collectively, our results provide evidence that the natural fibupeptide lugdunin acts as a peptidic channel that is spontaneously formed by an intricate stacking mechanism, leading to the dissipation of a bacterial cell’s membrane potential.
- 25 April 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Open AccessThe antimicrobial fibupeptide lugdunin forms water-filled channel structures in lipid membranes
Recently, a novel cyclo-heptapeptide composed of alternating d,l-amino acids and a unique thiazolidine heterocycle, called lugdunin, was discovered, which is produced by the nasal and skin commensal Staphylococcus lugdunensis. Lugdunin displays potent antimicrobial activity against a broad spectrum of Gram-positive bacteria, including challenging-to-treat methicillin-resistant Staphylococcus aureus (MRSA). Lugdunin specifically inhibits target bacteria by dissipating their membrane potential. However, the precise mode of action of this new class of fibupeptides remains largely elusive. Here, we disclose the mechanism by which lugdunin rapidly destabilizes the bacterial membrane potential using an in vitro approach. The peptide strongly partitions into lipid compositions resembling Gram-positive bacterial membranes but less in those harboring the eukaryotic membrane component cholesterol. Upon insertion, lugdunin forms hydrogen-bonded antiparallel β-sheets by the formation of peptide nanotubes, as demonstrated by ATR-FTIR spectroscopy and molecular dynamics simulations. These hydrophilic nanotubes filled with a water wire facilitate not only the translocation of protons but also of monovalent cations as demonstrated by voltage-clamp experiments on black lipid membranes. Collectively, our results provide evidence that the natural fibupeptide lugdunin acts as a peptidic channel that is spontaneously formed by an intricate stacking mechanism, leading to the dissipation of a bacterial cell’s membrane potential.
- Open Access
- 28 December 2023
- Published by Wiley in Chemistry – A European Journal
- Vol. 30 (10) , e202303435
Conformations and Rearrangements of Collinolactone – Experiments and Theory on a Dynamic Cyclodecatriene
Collinolactone A is a microbial specialized metabolite with a unique 6‐10‐7 tricyclic bislactone skeleton which was isolated from Streptomyces bacteria. The unusual cyclodecatriene motif features dynamic interconversions of two rotamers. Given the biological profiling of collinolactone A as neuroprotective agent, semisynthetic modifications represent an invaluable strategy to enhance its efficacy. Since understanding conformations and reactions of bioactive substances is crucial for rational structure‐based design and synthesis of derivatives, we conducted computational studies on conformational behavior as well as experiments on thermal and acid induced rearrangements of the cyclodecatriene. Experimental conformer ratios of collinolactone A and its biosynthetic ketolactone precursor are well reproduced by computations at the PW6B95‐D3/def2‐QZVPP//r2SCAN‐3c level. Upon heating collinolactone A in anhydrous dioxane at 100 °C, three collinolactone B stereoisomers exhibiting enollactone structures form via Cope rearrangements. Our computations predict the energetic preference for a boat‐like transition state in agreement with the stereochemical outcome of the main reaction pathway. Constriction of the ten‐membered ring forms collinolactone C with four annulated rings and an exocyclic double bond. Computations and semisynthetic experiments demonstrate strong preference for an acid‐catalyzed reaction pathway over an alternative Alder‐ene route to collinolactone C with a prohibitive reaction barrier, again in line with stereochemical observations.
- 28 December 2023
- Published by Wiley in Chemistry – A European Journal
- Vol. 30 (10) , e202303435
Open AccessConformations and Rearrangements of Collinolactone – Experiments and Theory on a Dynamic Cyclodecatriene
Collinolactone A is a microbial specialized metabolite with a unique 6‐10‐7 tricyclic bislactone skeleton which was isolated from Streptomyces bacteria. The unusual cyclodecatriene motif features dynamic interconversions of two rotamers. Given the biological profiling of collinolactone A as neuroprotective agent, semisynthetic modifications represent an invaluable strategy to enhance its efficacy. Since understanding conformations and reactions of bioactive substances is crucial for rational structure‐based design and synthesis of derivatives, we conducted computational studies on conformational behavior as well as experiments on thermal and acid induced rearrangements of the cyclodecatriene. Experimental conformer ratios of collinolactone A and its biosynthetic ketolactone precursor are well reproduced by computations at the PW6B95‐D3/def2‐QZVPP//r2SCAN‐3c level. Upon heating collinolactone A in anhydrous dioxane at 100 °C, three collinolactone B stereoisomers exhibiting enollactone structures form via Cope rearrangements. Our computations predict the energetic preference for a boat‐like transition state in agreement with the stereochemical outcome of the main reaction pathway. Constriction of the ten‐membered ring forms collinolactone C with four annulated rings and an exocyclic double bond. Computations and semisynthetic experiments demonstrate strong preference for an acid‐catalyzed reaction pathway over an alternative Alder‐ene route to collinolactone C with a prohibitive reaction barrier, again in line with stereochemical observations.
- Open Access
- 18 December 2023
- Published by Springer Nature in Nature Microbiology
- Vol. 9 (1) , 200-213
Commensal production of a broad-spectrum and short-lived antimicrobial peptide polyene eliminates nasal Staphylococcus aureus
Antagonistic bacterial interactions often rely on antimicrobial bacteriocins, which attack only a narrow range of target bacteria. However, antimicrobials with broader activity may be advantageous. Here we identify an antimicrobial called epifadin, which is produced by nasal Staphylococcus epidermidis IVK83. It has an unprecedented architecture consisting of a non-ribosomally synthesized peptide, a polyketide component and a terminal modified amino acid moiety. Epifadin combines a wide antimicrobial target spectrum with a short life span of only a few hours. It is highly unstable under in vivo-like conditions, potentially as a means to limit collateral damage of bacterial mutualists. However, Staphylococcus aureus is eliminated by epifadin-producing S. epidermidis during co-cultivation in vitro and in vivo, indicating that epifadin-producing commensals could help prevent nasal S. aureus carriage. These insights into a microbiome-derived, previously unknown antimicrobial compound class suggest that limiting the half-life of an antimicrobial may help to balance its beneficial and detrimental activities.
- 18 December 2023
- Published by Springer Nature in Nature Microbiology
- Vol. 9 (1) , 200-213
Open AccessCommensal production of a broad-spectrum and short-lived antimicrobial peptide polyene eliminates nasal Staphylococcus aureus
Antagonistic bacterial interactions often rely on antimicrobial bacteriocins, which attack only a narrow range of target bacteria. However, antimicrobials with broader activity may be advantageous. Here we identify an antimicrobial called epifadin, which is produced by nasal Staphylococcus epidermidis IVK83. It has an unprecedented architecture consisting of a non-ribosomally synthesized peptide, a polyketide component and a terminal modified amino acid moiety. Epifadin combines a wide antimicrobial target spectrum with a short life span of only a few hours. It is highly unstable under in vivo-like conditions, potentially as a means to limit collateral damage of bacterial mutualists. However, Staphylococcus aureus is eliminated by epifadin-producing S. epidermidis during co-cultivation in vitro and in vivo, indicating that epifadin-producing commensals could help prevent nasal S. aureus carriage. These insights into a microbiome-derived, previously unknown antimicrobial compound class suggest that limiting the half-life of an antimicrobial may help to balance its beneficial and detrimental activities.
- Open Access
- 12 December 2023
- Published by Wiley in Angewandte Chemie
- Vol. 136 (3)
Structure of Staphylococcus aureus ClpP Bound to the Covalent Active‐Site Inhibitor Cystargolide A
The caseinolytic protease is a highly conserved serine protease, crucial to prokaryotic and eukaryotic protein homeostasis, and a promising antibacterial and anticancer drug target. Herein, we describe the potent cystargolides as the first natural β‐lactone inhibitors of the proteolytic core ClpP. Based on the discovery of two clpP genes next to the cystargolide biosynthetic gene cluster in Kitasatospora cystarginea, we explored ClpP as a potential cystargolide target. We show the inhibition of Staphylococcus aureus ClpP by cystargolide A and B by different biochemical methods in vitro. Synthesis of semisynthetic derivatives and probes with improved cell penetration allowed us to confirm ClpP as a specific target in S. aureus cells and to demonstrate the anti‐virulence activity of this natural product class. Crystal structures show cystargolide A covalently bound to all 14 active sites of ClpP from S. aureus, Aquifex aeolicus, and Photorhabdus laumondii, and reveal the molecular mechanism of ClpP inhibition by β‐lactones, the predominant class of ClpP inhibitors.
- 12 December 2023
- Published by Wiley in Angewandte Chemie
- Vol. 136 (3)
Open AccessStructure of Staphylococcus aureus ClpP Bound to the Covalent Active‐Site Inhibitor Cystargolide A
The caseinolytic protease is a highly conserved serine protease, crucial to prokaryotic and eukaryotic protein homeostasis, and a promising antibacterial and anticancer drug target. Herein, we describe the potent cystargolides as the first natural β‐lactone inhibitors of the proteolytic core ClpP. Based on the discovery of two clpP genes next to the cystargolide biosynthetic gene cluster in Kitasatospora cystarginea, we explored ClpP as a potential cystargolide target. We show the inhibition of Staphylococcus aureus ClpP by cystargolide A and B by different biochemical methods in vitro. Synthesis of semisynthetic derivatives and probes with improved cell penetration allowed us to confirm ClpP as a specific target in S. aureus cells and to demonstrate the anti‐virulence activity of this natural product class. Crystal structures show cystargolide A covalently bound to all 14 active sites of ClpP from S. aureus, Aquifex aeolicus, and Photorhabdus laumondii, and reveal the molecular mechanism of ClpP inhibition by β‐lactones, the predominant class of ClpP inhibitors.
- Open Access
- 12 December 2023
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (3) , e202314028
Structure of Staphylococcus aureus ClpP Bound to the Covalent Active‐Site Inhibitor Cystargolide A
The caseinolytic protease is a highly conserved serine protease, crucial to prokaryotic and eukaryotic protein homeostasis, and a promising antibacterial and anticancer drug target. Herein, we describe the potent cystargolides as the first natural β‐lactone inhibitors of the proteolytic core ClpP. Based on the discovery of two clpP genes next to the cystargolide biosynthetic gene cluster in Kitasatospora cystarginea, we explored ClpP as a potential cystargolide target. We show the inhibition of Staphylococcus aureus ClpP by cystargolide A and B by different biochemical methods in vitro. Synthesis of semisynthetic derivatives and probes with improved cell penetration allowed us to confirm ClpP as a specific target in S. aureus cells and to demonstrate the anti‐virulence activity of this natural product class. Crystal structures show cystargolide A covalently bound to all 14 active sites of ClpP from S. aureus, Aquifex aeolicus, and Photorhabdus laumondii, and reveal the molecular mechanism of ClpP inhibition by β‐lactones, the predominant class of ClpP inhibitors.
- 12 December 2023
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (3) , e202314028
Open AccessStructure of Staphylococcus aureus ClpP Bound to the Covalent Active‐Site Inhibitor Cystargolide A
The caseinolytic protease is a highly conserved serine protease, crucial to prokaryotic and eukaryotic protein homeostasis, and a promising antibacterial and anticancer drug target. Herein, we describe the potent cystargolides as the first natural β‐lactone inhibitors of the proteolytic core ClpP. Based on the discovery of two clpP genes next to the cystargolide biosynthetic gene cluster in Kitasatospora cystarginea, we explored ClpP as a potential cystargolide target. We show the inhibition of Staphylococcus aureus ClpP by cystargolide A and B by different biochemical methods in vitro. Synthesis of semisynthetic derivatives and probes with improved cell penetration allowed us to confirm ClpP as a specific target in S. aureus cells and to demonstrate the anti‐virulence activity of this natural product class. Crystal structures show cystargolide A covalently bound to all 14 active sites of ClpP from S. aureus, Aquifex aeolicus, and Photorhabdus laumondii, and reveal the molecular mechanism of ClpP inhibition by β‐lactones, the predominant class of ClpP inhibitors.
- Open Access
- 29 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Resurrecting ancestral antibiotics: unveiling the origins of modern lipid II targeting glycopeptides
Antibiotics are central to modern medicine, and yet they are mainly the products of intra and inter-kingdom evolutionary warfare. To understand how nature evolves antibiotics around a common mechanism of action, we investigated the origins of an extremely valuable class of compounds, lipid II targeting glycopeptide antibiotics (GPAs, exemplified by teicoplanin and vancomycin), which are used as last resort for the treatment of antibiotic resistant bacterial infections. Using a molecule-centred approach and computational techniques, we first predicted the nonribosomal peptide synthetase assembly line of paleomycin, the ancestral parent of lipid II targeting GPAs. Subsequently, we employed synthetic biology techniques to produce the predicted peptide and validated its antibiotic activity. We revealed the structure of paleomycin, which enabled us to address how nature morphs a peptide antibiotic scaffold through evolution. In doing so, we obtained temporal snapshots of key selection domains in nonribosomal peptide synthesis during the biosynthetic journey from ancestral, teicoplanin-like GPAs to modern GPAs such as vancomycin. Our study demonstrates the synergy of computational techniques and synthetic biology approaches enabling us to journey back in time, trace the temporal evolution of antibiotics, and revive these ancestral molecules. It also reveals the optimisation strategies nature has applied to evolve modern GPAs, laying the foundation for future efforts to engineer this important class of antimicrobial agents.
- 29 November 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Open AccessResurrecting ancestral antibiotics: unveiling the origins of modern lipid II targeting glycopeptides
Antibiotics are central to modern medicine, and yet they are mainly the products of intra and inter-kingdom evolutionary warfare. To understand how nature evolves antibiotics around a common mechanism of action, we investigated the origins of an extremely valuable class of compounds, lipid II targeting glycopeptide antibiotics (GPAs, exemplified by teicoplanin and vancomycin), which are used as last resort for the treatment of antibiotic resistant bacterial infections. Using a molecule-centred approach and computational techniques, we first predicted the nonribosomal peptide synthetase assembly line of paleomycin, the ancestral parent of lipid II targeting GPAs. Subsequently, we employed synthetic biology techniques to produce the predicted peptide and validated its antibiotic activity. We revealed the structure of paleomycin, which enabled us to address how nature morphs a peptide antibiotic scaffold through evolution. In doing so, we obtained temporal snapshots of key selection domains in nonribosomal peptide synthesis during the biosynthetic journey from ancestral, teicoplanin-like GPAs to modern GPAs such as vancomycin. Our study demonstrates the synergy of computational techniques and synthetic biology approaches enabling us to journey back in time, trace the temporal evolution of antibiotics, and revive these ancestral molecules. It also reveals the optimisation strategies nature has applied to evolve modern GPAs, laying the foundation for future efforts to engineer this important class of antimicrobial agents.
- Open Access
- 18 August 2022
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 11 (8) , e0022022
Complete Genome Sequence of the Collinolactone Producer Streptomyces sp. Strain Gö40/10
The actinomycete Streptomyces sp. strain Gö40/10 has the potential to produce a range of secondary metabolites, one of which is collinolactone, a compound with neuroprotective properties and potential for pharmaceutical applications. The genome was sequenced with Oxford Nanopore Technologies MinION and Illumina MiSeq systems and consists of a single 9,635,564-nucleotide linear chromosome.
- 18 August 2022
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 11 (8) , e0022022
Open AccessComplete Genome Sequence of the Collinolactone Producer Streptomyces sp. Strain Gö40/10
The actinomycete Streptomyces sp. strain Gö40/10 has the potential to produce a range of secondary metabolites, one of which is collinolactone, a compound with neuroprotective properties and potential for pharmaceutical applications. The genome was sequenced with Oxford Nanopore Technologies MinION and Illumina MiSeq systems and consists of a single 9,635,564-nucleotide linear chromosome.